Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
Top Cited Papers
- 15 September 2001
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (18) , 3817-3827
- https://doi.org/10.1200/jco.2001.19.18.3817
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- Lessons learned from BRCA1 and BRCA2Oncogene, 2000
- Systemic adjuvant treatment for premenopausal node-negative breast cancerEuropean Journal Of Cancer, 2000
- Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5European Journal Of Cancer, 1999
- The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the BreastNew England Journal of Medicine, 1999
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesThe Lancet, 1997
- Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-upNew England Journal of Medicine, 1995
- “Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer: An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)European Journal of Cancer and Clinical Oncology, 1991
- Endocrine profile in breast cancer patients receiving chemotherapyBreast Cancer Research and Treatment, 1991
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988